ALS Glutamate Autoimmune diseases Regeneration Gene therapy Therapy Becker muscular dystrophy Congenital muscular dystrophy Brain Rare diseases Exercise PABPN1 Dilated cardiomyopathy Myotonic dystrophy Myositis Thymus Aged Rare neuromuscular diseases MBNL Dermatomyositis COVID-19 CMS Cardiomyopathy CRISPRi Muscle Antisense oligonucleotides Nuclear envelope RNA interference LMNA Transcriptomics Inflammation Satellite cells Autoantibodies Muscle regeneration Myoblasts Biomarkers Myotonic Dystrophy Cytoskeleton Skeletal muscle Centronuclear myopathy Calcium Mouse model Cytokines Myotonic Dystrophy type 1 Satellite cell Neuromuscular disease Genotype phenotype correlation OPMD RNA biology Lamin A/C LMNA gene Biomarker Heart failure DMD Male Dynamin 2 Laminopathy Outcome measures Fibrosis LMNA gene Myasthenia gravis Aging Neuromuscular junction Cell therapy Animals Muscular dystrophy Treatment Myogenesis Genetics Neuromuscular diseases Fabry disease Laminopathie Amyotrophic lateral sclerosis FSHD Astrocyte Spinal muscular atrophy Mice Motoneuron Duchenne muscular dystrophy Myotonic dystrophy type 1 CTG repeat contractions Myopathies Humans Autoimmunity Alternative splicing Trinucleotide repeat expansion Dystrophin Autophagy Errance diagnostique Long read sequencing Laminopathies AAV Mechanotransduction Lamin A/C Myasthenia Gravis MG Thérapie génique Transgenic mouse model Heart Myopathy Actin Congenital myopathy